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This study investigated the impact of ischemic mitral regurgitation (MR) severity and
viability on left ventricular (LV) reverse remodeling after cardiac resynchronization ther-
apy (CRT) in patients with ischemic cardiomyopathy. Severe MR and ischemic cardiomy-
opathy have been associated with lack of LV reverse remodeling after CRT. Fifty-seven
consecutive patients with ischemic MR, LV ejection fraction <35%, QRS duration >120
ms, and intraventricular dyssynchrony >50 ms were prospectively included. Stress echo-
cardiography was performed before CRT implantation. Viability in the region of the LV
pacing lead was defined as the presence of viability in 2 contiguous segments. Response to
CRT at 6 months was defined by evidence of >15% LV decrease in end-systolic volume.
Severe MR was defined by an effective regurgitant orifice (ERO) area >20 mm2. Thirty-
three patients (58%) were responders at follow-up. Baseline ERO area and prevalence of
severe MR were not different between responders and nonresponders (19 ! 11 vs 21 ! 13
mm2, p" 0.67; 52% vs 53%, p" 0.84). In responders, MR was decreased by 58% (ERO 19!
12 to 8 ! 6 mm2). In the presence of viability in the region of the pacing lead, 74% (n " 29
patients) were responders (sensitivity 88%, specificity 58%); in the subgroup of patients
with viability in the region of the pacing lead and severe MR, 83% (n " 17 patients) were
responders. In conclusion, LV remodeling is frequent and ischemic MR decrease important
in patients with viability in the region of the pacing lead without regard to MR
severity. © 2010 Elsevier Inc. All rights reserved. (Am J Cardiol 2010;106:31–37)
Ischemic heart disease is the most common cause of sys-
tolic left ventricular (LV) dysfunction. The prognosis of these
patients is particularly modulated by the extent of residual
viable myocardium. Cardiac resynchronization therapy
(CRT) improves LV function and geometry, exercise capac-
ity, and outcomes of appropriately selected patients with
heart failure.1–3 CRT leads to a decrease in mitral regurgi-
tation (MR) severity at rest and during exercise by an
increase of LV function and local synchronicity (decrease in
mechanical activation delay of papillary muscles).4–11 Re-
sponse to CRT largely depends on extent of LV dyssyn-
chrony, severity of LV remodeling, extent of scar tissue, and
possibility offered to the left ventricle to recruit function
(contractile reserve). Whether the presence of MR and its
severity could modulate the response to CRT is still con-
troversial. Several investigators have suggested that extent
of LV reverse remodeling could be lessened in patients with
significant MR, particularly in the setting of ischemic car-
diomyopathy.12–14 This study investigated the potential im-
pact of MR severity and myocardial contractile reserve on
acute and long-term responses to CRT in patients with
ischemic cardiomyopathy and significant LV dyssynchrony.
Methods
From May 2005 to March 2008, 57 patients (mean age
71! 8 years, 43 men, (75%) were prospectively enrolled in
the Institut Universitaire de Cardiologie et de Pneumologie
de Québec, Quebec, Canada (n " 34) and the University
Hospital of Sart Tilman, Liège, Belgium (n" 23). Inclusion
criteria were (1) New York Heart Association functional
class III and IV heart failure; (2) QRS duration !120 ms;
(3) persistent LV systolic dysfunction (LV ejection fraction
"35%); (4) ischemic cardiomyopathy; (5) basal LV dys-
synchrony !50 ms; (6) optimal medical treatment for heart
failure including angiotensin-converting enzyme inhibitors
or angiotensin receptor blocker antagonists diuretics, #-re-
ceptor blockers, and spironolactone when tolerated; and (7)
sinus rhythm. Patients with recent myocardial infarction or
coronary revascularization (#6 months) and presenting
standard contraindications to stress echocardiography were
excluded. All patients underwent coronary angiography be-
fore implantation to exclude treatable ischemic heart dis-
ease. The cause was considered ischemic in the presence of
significant coronary artery disease (!50% stenosis in!1 of
the major epicardial coronary arteries) and/or a history of
aDepartment of Cardiology, Institut Universitaire de Cardiologie et de
Pneumologie de Québec, Quebec, Quebec, Canada; bDepartment of Car-
diology, University Hospital, Sart Tilman, Liège, Belgium. Manuscript
received January 19, 2010; revised manuscript received and accepted
February 7, 2010.
Dr. Sénéchal received a grant from Institut de Cardiologie de Québec,
Quebec, Quebec, Canada.
*Corresponding author: Tel: 418-656-8711; fax: 418-656-4581.
E-mail address: mario.senechal@criucpq.ulaval.ca (M. Sénéchal).
0002-9149/10/$ – see front matter © 2010 Elsevier Inc. All rights reserved. www.ajconline.org
doi:10.1016/j.amjcard.2010.02.012
myocardial infarction or previous revascularization. All pa-
tients provided informed consent. The study protocol con-
formed to the ethical guidelines of the 1975 Declaration of
Helsinki and was approved by local ethics committee.
Patients underwent clinical examination, 12-lead electro-
cardiography, echocardiography at rest, and stress echocar-
diography including dobutamine stress echocardiography or
exercise stress echocardiography within the week before
biventricular pacing implantation. Echocardiography at rest
was also performed within 24 hours after device placement.
Acute responders to CRT were defined as presenting a
$15% increase in LV stroke volume.5 Follow-up clinical
and echocardiographic examinations were obtained at 6
months. Long-term responders were defined by !15% de-
crease in LV end-systolic volume.15 Echocardiographic
measurements were performed by 2 observers blinded to a
patient’s status using a Philips Sonos 5500 or 7500 instru-
ment with a 2.5-MHz transducer (Philips Medical Systems,
Amsterdam, The Netherlands) or a Vivid 7 imaging device
(GE Vingmed Ultrasound, Horten, Norway). LV volumes
and ejection fraction were measured using the modified
biplane Simpson rule. LV stroke volume was calculated by
multiplying the LV outflow tract area by the LV outflow
tract velocity–time integral measured by pulse-wave Dopp-
ler. Proximal isovelocity surface area was used to assess
MR severity and to measure effective regurgitant orifice
(ERO) area and regurgitant volume.16 Aortic and pulmo-
nary Doppler flows were recorded in the pulse mode from
the apical 4-chamber view and parasternal short-axis view,
respectively. Aortic and pulmonary ejection delays were
defined as the delay between onset of the QRS complex on
the surface electrocardiogram and onset of aortic and pul-
monary waves. Interventricular delay was defined as the
time difference between aortic and pulmonary electrome-
chanical delay.17 Tissue Doppler imaging was performed in
the pulse-wave Doppler mode from apical views to assess
longitudinal myocardial regional function, analyzing the
septal, inferior, lateral, anterior, and posterior walls.17 Ve-
locity profiles were recorded with a sample volume placed
in the middle of the basal segment of each wall. Gain and
filters were adjusted as needed to eliminate background
noise and to allow a clear tissue signal. Tissue Doppler
imaging signals were recorded at a sweep of 100 mm/s.
Electromechanical delay, defined as the delay between on-
set of the QRS complex on the surface electrocardiogram
and onset of the systolic tissue Doppler imaging wave, were
measured. Intraventricular asynchronism was defined as the
time difference between the shortest and longest electrome-
chanical delays among the 5 LV walls. Thirty-four patients
underwent dobutamine stress echocardiography with a low-
dose infusion; they received dobutamine 5, 10, 15, and 20
$g/kg/min in 3-minute stages, with echocardiographic im-
ages recorded at each stage.18 Heart rate and blood pressure
were monitored during each stage. Criteria for stopping the
dobutamine infusion included (1) hypotension (systolic
blood pressure #90 mm Hg), (2) angina, (3) significant
arrhythmias (atrial fibrillation, bigeminy, ventricular tachy-
cardia), and (4) obtainment of 85% maximal predicted heart
rate. Twenty-three patients underwent stress echocardiogra-
phy. A symptom-limited graded bicycle exercise test was
performed in a semisupine position on a tilting exercise
table. After an initial workload of 25 W maintained for 2
minutes, the workload was increased every 2 minutes by 25
W. Blood pressure and a 12-lead electrocardiogram were
recorded every 2 minutes; 2-dimensional echocardiographic
recordings were made throughout the test. During stress
echocardiography (exercise or dobutamine), regional wall
motion score index was assessed using the 16-segment
model recommended by the American Society of Echocar-
diography.19 Thus, a normal or hyperkinetic segment was
graded as 1, hypokinetic as 2, akinetic as 3, and dyskinetic
as 4. Peak stress images showing maximum augmentation
Table 1




(n " 33, 58%)
Nonresponders
(n " 24, 42%)
p Value
Age (years) 71! 8 71 ! 9 71 ! 8 0.90
Men 43 (75%) 24 (73%) 9 (38%) 0.58
QRS duration (ms) 162 ! 28 166 ! 30 157 ! 25 0.22
Left bundle branch block 27 (47%) 14 (42%) 13 (54%) 0.38
Right bundle branch block 4 (7%) 3 (9%) 1 (4%) 0.46
Intraventricular conduction delay 19 (33%) 10 (30%) 9 (37%) 0.57
PR interval (ms) 189 ! 42 185 ! 38 193 ! 47 0.5
Pacing before cardiac resynchronization therapy 7 (12%) 6 (18%) 1 (4%) 0.09
New York Heart Association class III/IV 42 (74%)/15 (26%) 25 (76%)/8 (24%) 17 (71%)/7 (29%) 0.68
Medications
Diuretic 54 (95%) 31 (94%) 23 (96%) 0.75
# blockers 49 (86%) 27 (82%) 22 (92%) 0.28
Angiotensin-converting enzyme inhibitor 42 (74%) 25 (77%) 17 (71%) 0.68
Angiotensin receptor blockers 12 (21%) 7 (22%) 5 (21%) 0.92
Digoxin 10 (17%) 3 (9%) 7 (29%) 0.05
Spironolactone 31 (54%) 16 (48%) 15 (62%) 0.29
Lead placement
Posterior 30 (53%) 16 (48%) 14 (58%) 0.46
Lateral 27 (47%) 17 (51%) 10 (42%) 0.46
Anterior 0 — — —
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of the wall motion score index were compared to baseline
images. A segment was considered to have contractile re-
serve if the wall motion score index improved by !1 grade.
Viability in the region of the LV pacing lead was defined as
the presence of viability in 2 contiguous segments. Presence
of LV contractile reserve was defined as an improvement of
!0.20 in wall motion score index (at rest/stress).18 A cor-
onary sinus venogram was obtained using a balloon cathe-
ter, followed by insertion of the LV pacing lead (Guidant
Corp., St. Paul, Minnesota; or Medtronic, Inc., Minneapolis,
Minnesota) in the coronary sinus. The preferred position
was a lateral or posterolateral vein. Right atrial and ventric-
ular leads were positioned conventionally. All leads were
connected to a dual-chamber biventricular pacing (Guidant
Corp. or Medtronic, Inc.). After successful implantation,
echocardiography was used to optimize the atrioventricular
delay to maximize LV filling time. Interventricular pacing
interval was set to a default value (VV 0 ms). One day after
implantation, the LV lead position was assessed from a
chest x-ray, using frontal and lateral views (scored anterior,
lateral, or posterior).20
Results are expressed as mean ! SD or number (per-
centage). Baseline data of responders versus nonresponders
were compared for statistical significance using t test, chi-
square test, or Fisher’s exact test as appropriate. Echocar-
diographic data at baseline and after CRT were compared
within groups using paired t test. Linear regression analyses
were used to evaluate the relation between CRT response
echocardiographic data.
Results
Table 1 presents baseline characteristics of the popula-
tion before CRT. Device implantation was successful in all
patients and 1 patient developed pneumothorax after CRT
implantation. LV pacing thresholds were not different be-
Figure 1. Correlation between percent changes in LV end-systolic volume






(n " 33, 58%)
Nonresponders
(n " 24, 42%)
p Value
Asynchronism
Interventricular (ms) 44 ! 23 41 ! 26 48 ! 21 0.34
Intraventricular (ms) 87 ! 31 90 ! 33 82 ! 26 0.31
Left ventricular geometry and function
Left ventricular end-diastolic volume (ml)
Before cardiac resynchronization therapy 204 ! 56 195 ! 55 217 ! 57 0.16
Late after cardiac resynchronization therapy 195 ! 66 173 ! 56* 223 ! 69 0.0043
Left ventricular end-systolic volume (ml)
Before cardiac resynchronization therapy 163 ! 56 155 ! 53 173 ! 59 0.22
Late after cardiac resynchronization therapy 140 ! 62 120 ! 48* 169 ! 68 0.0021
Left ventricular stroke volume (ml)
Before cardiac resynchronization therapy 46 ! 12 43 ! 11 50 ! 12 0.03
Late after cardiac resynchronization therapy 54 ! 13 56 ! 12* 51 ! 14 0.16
Left ventricular ejection fraction (%)
Before cardiac resynchronization therapy 22 ! 8 22 ! 7 24 ! 8 0.33
Late after cardiac resynchronization therapy 29 ! 10 32 ! 10* 25 ! 9 0.01
Viability
Contractile reserve 33 (58%) 25 (76%) 8 (33%) 0.003
Viability in region of lead 40 (70%) 29 (88%) 11 (46%) 0.0005
Wall motion score index rest 2.95 ! 0.7 2.90 ! 0.6 3.0 ! 0.7 0.57
Wall motion score index stress 2.60 ! 0.7 2.50 ! 0.7 2.80 ! 0.8 0.20
Mitral regurgitation
Effective regurgitant orifice area (mm2)
Before cardiac resynchronization therapy 20 ! 12 19 ! 12 20 ! 13 0.67
Late after cardiac resynchronization therapy 12 ! 11 8 ! 6* 18 ! 14 0.001
Regurgitant volume (ml)
Before cardiac resynchronization therapy 33 ! 27 35 ! 31 30 ! 21 0.60
Late after cardiac resynchronization therapy 23 ! 20 16 ! 14* 34 ! 22 0.006
* Significant difference (p #0.05) between data before and late after cardiac resynchronization therapy.
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tween responders and nonresponders (1.18 ! 0.70 vs 1.75 !
0.5, p " 0.17). During stress echocardiography, no patients
demonstrated angina or electric or regional wall motion
modification at peak stress suggesting ischemia. The day
after CRT implantation, 28 patients (49%) were acute re-
sponders (increased LV stroke!15%), whereas at 6 months
33 patients (58%) were classified as long-term responders
(decrease in LV end-systolic volume !15%). Baseline LV
volumes, LV ejection fraction, LV wall motion score index
at rest and stress, MR severity, interventricular mechanical
delay, and LV asynchrony were not significantly different
between long-term responders and nonresponders (Table 2).
Nonresponder patients had larger baseline LV stroke vol-
ume than responders, but after CRT this difference was no
longer significant. As expected, LV geometry and function
and MR severity were significantly improved in responders.
All patients completed the stress echocardiographic pro-
tocol without complications. Absolute changes (r " 0.32,
p " 0.01) and percent changes (r " 0.35, p " 0.008) in LV
stroke volume 24 hour after CRT implantation were directly
related to changes in wall motion score index. Percent
changes in LV end-systolic volume at 6 months were sig-
nificantly correlated with the peak wall motion score index
(r " 0.49, p " 0.0002) and percent changes in wall motion
score index (r " 0.46, p " 0.0004) during stress echocar-
diography (Figure 1). Similar correlations were observed in
ERO decrease at 6 months (r " 0.36, p " 0.007). Contrac-
tile reserve was present in 33 patients (58%). Acute and
long-term responders had a higher prevalence of contractile
reserve than nonresponders (74% vs 43%, p" 0.02; 76% vs
33%, p " 0.003, respectively; Table 2). Presence of con-
tractile reserve had, respectively, a sensitivity and specific-
ity to predict acute (74% and 57%) and long-term (75% and
65%) responses to CRT. Presence of viability in the region
of the pacing lead was more frequent in acute and long-term
responders than in nonresponders (Figure 2). LV lead po-
sitioned in a region with viability was associated with
greater LV end-systolic volume decrease (%6 ! 14% vs
%20 ! 17%, p " 0.006; Figure 3). Viability in the region
of the pacing lead predicted acute and long-term responses
Figure 2. Percentage of (A) acute and (B) 6 months responders (white bars)
and non responders (black bars) to CRT based on the presence or absence
of viability in the region of the pacing lead.
Figure 3. Changes in LVES volume after CRT in responders (white bar)
and nonresponders (black bar) based on presence of viability in the region
of the pacing lead. Abbreviation as in Figure 1.
Figure 4. ERO area at baseline, soon after CRT (i.e., #48 hours) and at 6
months after CRT in responders and nonresponders. *Significant difference
from baseline; †significant difference from soon after CRT.
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with sensitivities of 93% and 88% and specificities of 54%
and 57%, respectively. There was no significant difference
in baseline MR severity and prevalence of severe MR be-
tween groups (Figures 4 and 5). ERO and regurgitant vol-
ume were significantly decreased after CRT in responders,
whereas there was no significant change in nonresponders
(Table 2). In responders, ERO was decreased by 58% (from
19! 12 mm2 to 8! 6 mm2, p" 0.001) at 6 months (Figure
5). Responders had a lower prevalence of severe MR after
CRT than nonresponders. There was good correlation be-
tween changes in ERO and changes in LV end-systolic
volume (r " 0.44, p " 0.0015). Long-term responders were
more frequent in patients with the combined presence of
severe MR and viability in the region of the pacing lead
(Figure 6).
Discussion
In patients with ischemic LV dysfunction and significant
LV dyssynchrony, response to CRT is modulated by several
factors. In the present study, we confirm that acute and
long-term benefits to CRT depend not only on the presence
of LV dyssynchrony but also on the extent of residual
myocardial viability and severity of MR. A direct relation
existed between extent of myocardial contractile recruit-
ment during stress echocardiography and extent of LV re-
verse remodeling. Conversely, absence of contractile re-
serve particularly in the region of the pacing lead is likely
associated with less or no decrease in LV end-systolic
volume after CRT.
A range of echocardiographic and clinical variables have
been proposed as possible markers of nonresponse, includ-
ing cause of the underlying heart disease.12,13,21–24 It is still
a point of discussion whether the ischemic origin of the
disease is a predictor of nonresponse. Previous studies have
shown that having heart failure from ischemic origin par-
ticularly if associated with severe MR is a predictor of lack
of response to CRT.12–14 In the same line Sutton et al15
demonstrated that reverse remodeling after CRT occurred
mainly in nonischemic patients. Conversely, Molhoek et
al21 showed that the underlying cause of heart failure was
not related to CRT response. In a study including 106
patients, Vidal et al22 observed at 12-month follow-up that
patients with LV systolic dysfunction and left bundle branch
block treated by CRT showed clinical improvements and
reverse remodeling irrespective of the cause of their cardi-
opathy. This discrepancy between studies suggests that re-
sponse to CRT is a multifactor process that may include
severity of intraventricular asynchrony, presence and local-
ization of LV viability, and presence and severity of MR.
In our study all patients had heart failure from ischemic
origin and significant intraventricular asynchronism (!50
ms, mean 87 ! 31) that was above the cut-off value of !65
ms suggested in previous studies as having the best combi-
nation of sensitivity and specificity to predict acute and
long-term CRT responses.5 In studies including patients
with systolic dysfunction of ischemic and nonischemic or-
igins and significant LV asynchrony, LV remodeling at 6
months has been usually !70%.14,25 In accordance with
previous studies, our results suggest that in a population of
patients with heart failure of ischemic origin,12,23 LV re-
modeling at 6 months is less frequent (i.e., 58%) than in
patients with other heart failure causes. Nonetheless, our
study demonstrated that in the presence of significant asyn-
chrony and viability in the region of the pacing lead, long-
term LV remodeling in patients with ischemic cardiomyop-
athy is observed in 74% of patients.
By decreasing dyssynchrony, CRT has the potential to
decrease ischemic MR. Effects of CRT on ischemic MR
may occur early and late after CRT. CRT acutely decreases
MR by increasing the closing force and decreasing the
tethering forces acting on the mitral valve apparatus. CRT
also decreases MR by co-ordinating contraction of papillary
muscles.11 Long-term LV remodeling may explain the sub-
sequent MR decrease during follow-up. Pooled data from 5
major studies of$350 patients with implanted biventricular
devices, followed for$6 months, showed a decrease of MR
by 30% to 40%.13 In our study ERO was decreased by 58%
at 6 months. The main ERO decrease occurred at 24 hours
after CRT implantation, suggesting that acute resynchroni-
zation of the papillary muscle and an improved closing
force are the main mechanisms explaining this impressive
Figure 5. Prevalence of severe MR at baseline (black bars) and at 6 months
(white bars) between responders and nonresponders. *Significant differ-
ence from nonresponders.
Figure 6. Percentage of responders (white bars) versus nonresponders
(black bars) to CRT according to presence of viability in the region or the
pacing lead (viab!) and the presence of severe MR (ERO !20 mm2).
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early MR decrease (Figure 4). The influence of MR severity
on CRT response is conflicting. Some investigators shown
that patients with severe MR have a lesser chance of show-
ing improvement with CRT.12–14 However, these studies
included a limited number of patients. In the Cardiac Re-
synchronization in Heart Failure (CARE-HF) study, a ran-
domized trial including a large number of patients, it was
conversely shown that patients who showed no improve-
ment were likely to have no significant MR compared to
responders.26 The results of the present study confirm and
extend this observation. Of interest, responders were more
frequent (82%) in the subgroup of patients with residual
viability in the region of the pacing lead and severe MR.
In patients with severe decreased LV function, identifi-
cation of contractile reserve during stress echocardiography
has been shown to provide important prognostic informa-
tion in patients with heart failure. More specifically in pa-
tients referred to CRT, few investigators have reported that
the presence of viability in the region of the pacing lead
might modulate the response to CRT.27,28 Our data are in
line with these considerations. Extent of LV global contrac-
tile reserve was related to percent acute changes in forward
stroke volume and to extent of decrease in end-systolic
volume. The role of residual viability in the stimulated LV
area has been recently highlighted. Patients with transmural
scar in the posterolateral region as assessed by contrast-
enhanced magnetic resonance imaging showed not im-
provement under stimulation.27 Similarly, absence of con-
tractile reserve in the region of the LV pacing as manifested
by no significant changes in wall motion score during stress
echocardiography precludes LV reverser remodeling in
most patients.29,30 In line with these data, we found that
responders to CRT showed greater wall motion improve-
ment in the region of the LV pacing lead during stress
compared to nonresponders. Furthermore, these data indi-
cate that a substantial amount of recruitable myocardium is
needed to obtain improvement in LV function after CRT.
These results should be regarded cautiously and some
limitations should be underlined. Although the difference
was not statistically different, more nonresponders took
digoxin and spironolactone than responders. Therefore, be-
cause of the sample (n " 57) and heterogeneity of the
population studied, those data should be confirmed by suit-
ably powered clinical trials that are undoubtedly needed.
Also, dyssynchrony was defined by longitudinal tissue
Doppler imaging using a cut-off value of 50 ms as the
inclusion criterion. Combining longitudinal and radial dys-
synchrony indexes as inclusion criteria could have been
helpful in choosing a more homogenous population prone to
CRT response.
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